Results 101 to 110 of about 197,499 (175)

Isolated Growth Hormone Deficiency

Endocrines
Growth hormone deficiency (GHD) is the most frequent pituitary hormone deficiency in childhood, with an incidence of 1 in 4000–10,000 live births. GHD can be congenital (genetic or due to hypothalamic/pituitary abnormalities) or acquired and can be ...
Anastasia Ibba, Chiara Guzzetti, Lavinia Sanfilippo, Sandro Loche   +3 more
doaj   +1 more source

First Clinical Study on Long-Acting Growth Hormone Therapy in Children with Turner Sydrome. [PDF]

Horm Metab Res, 2022
Gao X, Chen J, Cao B, Dou X, Peng Y, Su C, Qin M, Wei L, Fan L, Zhang B, Gong C.   +10 more
europepmc   +1 more source

Patients with Growth-Related Disorders and Caregivers Prefer the Somapacitan Device to the Somatrogon Device: Results from a Randomized Crossover Study Assessing Device Preference and Ease of Use Following Simulated Injections

Medical Devices: Evidence and Research
Shahid Akhtar,1 Birgitte Berg,2 Johan Medina,3 Maya Nicole Gonczi,4 Sophie Hamilton,5 Emily Hildebrand,4 Nicky Kelepouris,6 Jesper Skov Neergaard,7 Claus Sværke,8 Gitte Ter-Borch,2 Niklas Kahr Rasmussen3 1Devices & Digital Health, Novo Nordisk A/S ...
Akhtar S, Berg B, Medina J, Gonczi MN, Hamilton S, Hildebrand E, Kelepouris N, Neergaard JS, Sværke C, Ter-Borch G, Rasmussen NK   +10 more
doaj  

Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®

Patient Preference and Adherence, 2011
Kevin CJ Yuen1, Rakesh Amin21Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA; 2Barts and The London Children’s Hospital, London, UKAbstract ...
Kevin CJ Yuen, Rakesh Amin
doaj  

Long-acting Growth Hormone Therapy: A REAL3 Alternative to Daily Growth Hormone Treatment?

The Journal of Clinical Endocrinology & Metabolism, 2020
Vaneeta Bamba, Michael A Levine
openaire   +2 more sources

Optimization of dosing regimens for the long-acting growth hormone pegpesen: A population PK/PD modeling approach. [PDF]

J Endocrinol Invest
Zhao Y, Zou F, Gu J, He R, Yin Y.
europepmc   +1 more source

Tissue Distribution and Receptor Activation by Somapacitan, a Long Acting Growth Hormone Derivative. [PDF]

Int J Mol Sci, 2020
Petersen M, Gandhi PS, Buchardt J, Alanentalo T, Fels JJ, Johansen NL, Helding-Kvist P, Vad K, Thygesen P.   +8 more
europepmc   +1 more source

The Use of IGF-I to Monitor Long-Acting Growth Hormone Therapy-Timing is an Art….

J Clin Endocrinol Metab, 2021
Bidlingmaier M, Schilbach K.
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 13 No. 1 [PDF]

, 1977

core   +1 more source

Arkansas Animal Science Department Report 2015 [PDF]

, 2015
Apple, Jason, Beck, Paul, Kegley, Beth, Rosenkrans, Charles, Jr.   +3 more
core   +2 more sources